Right Ventricular Dysfunction Is Associated with Mortality in Non-Small Cell Lung Cancer

Affiliations

Editorial

Lindsay M Forbes. Ann Am Thorac Soc. 2025 Jul.

. 2025 Jul;22(7):979-981.

doi: 10.1513/AnnalsATS.202505-506ED.

¹ Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado.

No abstract available

Figures

Echocardiographic Measure of Right Ventricular-Pulmonary Arterial Coupling Predicts Survival in Lung Cancer.
Rako ZA, Cekay M, Yogeswaran A, Yildiz S, Arndt PF, Kremer N, Schäfer S, Janetzko P, Thal BR, Mummert CM, Franken JK, Soethe H, Werner HF, Dumitrascu R, Grimminger F, Ghofrani HA, Pullamsetti SS, Seeger W, Naeije R, Savai R, Eul B, Tello K. Rako ZA, et al. Ann Am Thorac Soc. 2025 Jul;22(7):1071-1078. doi: 10.1513/AnnalsATS.202409-949OC. Ann Am Thorac Soc. 2025. PMID: 40042816

1. Garry JD, Kundu S, Annis J, Alcorn C, Eden S, Smith E. et al. Incidence of pulmonary hypertension in the echocardiography referral population. Ann Am Thorac Soc . 2025;22:679–688. - PMC - PubMed
1. Shlobin OA, Adir Y, Barbera JA, Cottin V, Harari S, Jutant EM. et al. Pulmonary hypertension associated with lung diseases. Eur Respir J . 2024;64:2401200. - PMC - PubMed
1. Gutor SS, Richmond BW, Agrawal V, Brittain EL, Shaver CM, Wu P. et al. Pulmonary vascular disease in Veterans with post-deployment respiratory syndrome. Cardiovasc Pathol . 2024;71:107640. - PubMed
1. Eul B, Cekay M, Pullamsetti SS, Tello K, Wilhelm J, Gattenlöhner S. et al. Noninvasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with lung cancer. Am J Respir Crit Care Med . 2021;203:1316–1319. - PubMed
1. Mędrek S, Szmit S. Baseline electrocardiographic and echocardiographic assessment may help predict survival in lung cancer patients: a prospective cardio-oncology study. Cancers (Basel) . 2022;14:2010. - PMC - PubMed